Persistent Dyslipidemia in HIV-Infected Individuals Switched From a Protease Inhibitor-Containing to an Efavirenz-Containing Regimen
- 1 April 2001
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 26 (4), 389-390
- https://doi.org/10.1097/00042560-200104010-00018
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in AdultsNew England Journal of Medicine, 1999
- Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease InhibitorsCirculation, 1999
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- EfavirenzDrugs, 1998
- Trends in Cardiovascular Risk Factors (1984–1993) in a Swiss Region: Results of Three Population SurveysPreventive Medicine, 1997